Switch theme
Sign up to access all valuation multiples
Cofoe Medical Technology Co Ltd is engaged in the research and development, production, sales and service of home medical equipment.
2009
n/a
LTM Revenue $461M
LTM EBITDA n/a
$699M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Cofoe Medical has a last 12-month revenue of $461M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Cofoe Medical achieved revenue of $393M and an EBITDA of $60.0M.
Cofoe Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Cofoe Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $393M | $442M | XXX | XXX | XXX |
| Gross Profit | $137M | $162M | XXX | XXX | XXX |
| Gross Margin | 35% | 37% | XXX | XXX | XXX |
| EBITDA | $60.0M | n/a | XXX | XXX | XXX |
| EBITDA Margin | 15% | NaN% | XXX | XXX | XXX |
| Net Profit | $59.1M | $41.6M | XXX | XXX | XXX |
| Net Margin | 15% | 9% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Cofoe Medical's stock price is CNY 33 (or $4).
Cofoe Medical has current market cap of CNY 6.8B (or $938M), and EV of CNY 5.1B (or $699M).
See Cofoe Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $699M | $938M | XXX | XXX | XXX | XXX | $0.26 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Cofoe Medical has market cap of $938M and EV of $699M.
Cofoe Medical's trades at 1.5x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Cofoe Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Cofoe Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $699M | XXX | XXX | XXX |
| EV/Revenue | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | 19.1x | XXX | XXX | XXX |
| P/E/Growth | 0.7x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpCofoe Medical's NTM/LTM revenue growth is 16%
Cofoe Medical's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Cofoe Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Cofoe Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Cofoe Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
| Opex per Employee | n/a | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 4% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 34% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cofoe Medical acquired XXX companies to date.
Last acquisition by Cofoe Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . Cofoe Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Cofoe Medical founded? | Cofoe Medical was founded in 2009. |
| Where is Cofoe Medical headquartered? | Cofoe Medical is headquartered in China. |
| Is Cofoe Medical publicy listed? | Yes, Cofoe Medical is a public company listed on SHE. |
| What is the stock symbol of Cofoe Medical? | Cofoe Medical trades under 301087 ticker. |
| When did Cofoe Medical go public? | Cofoe Medical went public in 2021. |
| Who are competitors of Cofoe Medical? | Similar companies to Cofoe Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Cofoe Medical? | Cofoe Medical's current market cap is $938M |
| What is the current revenue of Cofoe Medical? | Cofoe Medical's last 12-month revenue is $461M. |
| What is the current EV/Revenue multiple of Cofoe Medical? | Current revenue multiple of Cofoe Medical is 1.5x. |
| What is the current revenue growth of Cofoe Medical? | Cofoe Medical revenue growth between 2023 and 2024 was 12%. |
| Is Cofoe Medical profitable? | Yes, Cofoe Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
